Cabozantinib 849217-68-1 XL-184 XL 184 XL-184 free base BMS-907351 BMS 907351 N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide CHEBI:72317 1C39JW444G BMS-907351 FREE BASE XL184 cpd BMS907351 DTXSID10233968 1,1-Cyclopropanedicarboxamide, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)- N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide cabozantinibum 1,1-CYCLOPROPANEDICARBOXAMIDE, N'-(4-((6,7-DIMETHOXY-4-QUINOLINYL)OXY)PHENYL)-N-(4-FLUOROPHENYL)- N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N-[4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide RefChem:57604 DTXCID40156459 L01XE26 Cometriq Cabozantinib (XL184, BMS-907351) MFCD20926324 N'-[4-[(6,7-DIMETHOXY-4-QUINOLINYL)OXY]PHENYL]-N-(4-FLUOROPHENYL)-1,1-CYCLOPROPANEDICARBOXAMIDE Cabozantinib [USAN] 1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Cabozantinib (USAN) Cabometyx (TN) Cometriq (TN) A1JS8 N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide n-(4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-n'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide N1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N1'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Cabozantinib [USAN:INN] Carbozantinib UNII-1C39JW444G Cabozantinib (BMS-907351) Cabozantinib; N'-?[4-?[(6,?7-?Dimethoxy-?4-?quinolinyl)?oxy]?phenyl]?-?N-?(4-?fluorophenyl)?-1,?1-cyclopropanedicarbox?amide; N'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; BMS 907351; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide Cabozantinib (Standard) CABOZANTINIB [MI] Cabozantinib (XL-184) CABOZANTINIB [INN] CABOZANTINIB [VANDF] CABOZANTINIB [WHO-DD] SCHEMBL360795 GTPL5887 orb1305297 CHEMBL2105717 SCHEMBL29351408 EX-A075 GLXC-90066 HMS3654G06 HMS5079K09 XL-184 free base (Cabozantinib) BDBM50021574 EBC-17137 HY-13016R NSC761068 NSC800066 s1119 AKOS025142112 CCG-264678 CS-0278 DB08875 FD59688 NSC-761068 NSC-800066 SB20062 SDCCGSBI-0646928.P001 XL-184 (Cabozantinib,BMS907351) XL-184,Cabozantinib, BMS-907351 NCGC00263164-01 NCGC00263164-12 NCGC00263164-14 NCGC00263164-17 AC-25082 AS-16277 BP-43629 HY-13016 SY097158 XL-184 (Cabozantinib,BMS907351)? DB-023624 NS00020240 SW218093-3 D10062 AB01565831_02 Q795057 SR-01000941569 SR-01000941569-1 BRD-K51544265-001-01-8 BRD-K51544265-001-04-2 BRD-K51544265-001-06-7 1,1-Cyclopropanedicarboxamide, N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)- 1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)- cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide(4-fluoro-phenyl)-amide cyclopropane-1,1-dicarboxylic acid[4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4 fluorophenyl)cyclopropane-1,1-dicarboxamide N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide N~1~-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl}-N'~1~-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
Mostrar todos os 102 sinônimos 
